NEW YORK--(BUSINESS WIRE)--Tema ETFs ("Tema†), the New York-based manager of innovative exchange-traded funds (ETFs), is pleased to announce the Tema Oncology ETF ("CANC†) has surpassed $100m in assets under management (AUM) two years since launch. The CANC ETF invests in leading oncology companies and cancer therapies and is the only pure-play oncology focused ETF in the world, managed by Dr. David Song MD, PhD, CFA.1 Key Highlights of the Tema Oncology ETF (CANC): 1. Rising Oncology Need Canc. ...